Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959542 · ClinicalTrials.gov registry record · NA
Early Changes In Multiparametric MRI In Prostate Cancer
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01959542 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 15 participants.
The verdict
NCT01959542, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
In this research study, the investigators are trying to determine if there are measurable changes in prostate MRI that will help predict those who will or will not respond to Androgen Deprivation Therapy (ADT) and External Beam Radiation Therapy (EBRT) The first baseline prostate MRI prior to the start of treatment is standard of care. The participant's ADT/EBRT treatment is also standard of care, as advised by their doctor. It is the 3 follow up prostate MRIs during ADT/EBRT treatment, and 4 follow up serum PSA levels that are part of this research study.
Interventions
- DEVICE MRI
- OTHER PSA Blood Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959542
The ClinicalTrials.gov registry entry for NCT01959542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT01959542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01959542 about?
NCT01959542 is a clinical study titled "Early Changes In Multiparametric MRI In Prostate Cancer". In this research study, the investigators are trying to determine if there are measurable changes in prostate MRI that will help predict those who will or will not respond to Androgen Deprivation Therapy (ADT) and External Beam Radiation Therapy (EBRT) The first baseline prostate MRI prior to the st...
What is the current status of trial NCT01959542?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-12. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01959542?
The interventions under investigation include: MRI (DEVICE), PSA Blood Test (OTHER).
Who is sponsoring clinical trial NCT01959542?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.